Neos Therapeutics, Inc.

No reviews yet · Write a Review
Neos Therapeutics develops, manufactures, and commercializes innovative extended-release (XR) products using our proprietary extended-release drug delivery and orally disintegrating tablet (ODT) technology platforms. We have three approved ADHD products, two of which use our ODT technology and one of which is an ER oral suspension. Our growing ADHD product portfolio puts Neos in a unique position to help meet the different needs of patients who struggle with ADHD.

Company Details

Address
2940 N Hwy 360, #100
Grand Prairie, TX 75050

Competitors of Neos Therapeutics, Inc.

Zylo Therapeutics is a South Carolina-based company that develops and markets sustained-release drug-delivery systems for the pharmaceutical industry. Depending on the characteristics of a specific compound, Z-pods® can be adapted to improve stability, provide targeted delivery, and increase... Read More

0 Products 0 White Papers 0 Press Releases

Ascendia Pharmaceutical Solutions is a specialty contract development and manufacturing organization (CDMO) based in North Brunswick, NJ. Ascendia focuses on developing innovative formulations for complex drug products utilizing proprietary technologies to improve solubility, bioavailability, and... Read More

0 Products 0 White Papers 0 Press Releases

Eastman is a global specialty chemical company that produces a broad range of products found in items people use every day. With a portfolio of specialty businesses, Eastman works with customers to deliver innovative products and solutions while maintaining a commitment to safety and... Read More

0 Products 0 White Papers 0 Press Releases